Viewing Study NCT00026494


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-02-23 @ 12:21 PM
Study NCT ID: NCT00026494
Status: COMPLETED
Last Update Posted: 2016-01-18
First Post: 2001-11-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tumors metastatic to brain View